Mark Hillman’s Colgate-Palmolive CL Stock Holding History

Mark Hillman’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-12,000	Closed	-$728K	–	40
2013 Q2	$728K	Buy	+12,000	New	+$712K	1.01%	39

Other funds holding CL

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mark Hillman's CL Position: Q3 2013 in Review

Mark Hillman sold out of Colgate-Palmolive (CL) in Q3 2013, closing a stake of 12,000 shares — an estimated $728K sold.

Mark Hillman first reported a position in CL in Q2 2013 and held it in 1 quarter. The position peaked at $728K in Q2 2013. 1,092 funds tracked by Wall St. Rank hold CL as of Q3 2013.

Mark Hillman reported no remaining Colgate-Palmolive position as of Q3 2013 after selling out during the quarter.
Mark Hillman sold 12,000 Colgate-Palmolive shares in Q3 2013, an estimated $728K.
Mark Hillman first reported a position in Colgate-Palmolive in Q2 2013 and held it in 1 quarter.
Mark Hillman's Colgate-Palmolive position peaked at $728K in Q2 2013.
1,092 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2013.

Based on Hillman Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.